Safety and efficacy of dendritic cell-based immunotherapy (DCVAC/LuCa) combined with carboplatin/pemetrexed for patients with advanced non-squamous non-small-cell lung cancer without oncogenic drivers

BACKGROUND: Our prospective, open-label, single-arm phase II study investigated the safety and efficacy of DCVAC/LuCa (dendritic cell vaccines for lung cancer) combined with standard carboplatin/pemetrexed in advanced non-squamous (nsq) non-small-cell lung cancer (NSCLC). PATIENTS AND METHODS: Eligi...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhong, R., Ling, X., Cao, S., Xu, J., Zhang, B., Zhang, X., Wang, H., Han, B., Zhong, H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8718955/
https://www.ncbi.nlm.nih.gov/pubmed/34959168
http://dx.doi.org/10.1016/j.esmoop.2021.100334

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8718955/
https://www.ncbi.nlm.nih.gov/pubmed/34959168
http://dx.doi.org/10.1016/j.esmoop.2021.100334

Ejemplares similares